x

This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 




Myriad: the oral arguments

16-04-2013

On Monday, April 15, the US Supreme Court heard oral arguments on whether genetic material is patent eligible subject matter and in particular, whether Utah-based Myriad Genetics’ patents covering isolated human genes linked to breast and ovarian cancer are valid and enforceable.


Myriad, gene patents, US Supreme Court, oral arguments, BRCA1

WIPR

Payment types accepted